All tenants at BioPark
(in the BioPark, founded in 2002, 20 employees) focuses on the development and marketing of innovative immune diagnostic systems to improve therapy control and personalized treatment of patients in the area of transplantation, infectious and autoimmune diseases. The company’s developments are based on its expertise in cell-mediated immunity as well as on its proprietary T-activation® and Reverse T Cell Technology platforms.
(in the BioPark, founded in 2004, 48 employees) develops and markets integrated test systems for human diagnostics. The fully automated numares systems provide information about formation, extent and severity of diseases in high throughput operations. They ensure improved treatment options at high patient safety and cost-effectiveness.
(in the BioPark, founded in 2009, 6 employees) is a science-based company tackling Androgenetic Alopecia (AGA), which is commonly known as male and female pattern baldness. The company is developing novel effective health and beauty therapies to help people stay young and healthy longer and to extend their quality of life.
(in the BioPark, founded in 1997, 84 employees) developer and manufacturer of chemical optical sensors and systems for customers in Biotechnology, Pharmacy, Medical Devices, Food Industry and in many other scientific fields.
The “Regensburg Center of Biomedical Engineering” (RCBE) is an inter-faculty and inter-university research institute of the Ostbayerische Technische Hochschule Regensburg (OTH Regensburg) and the Regensburg University (UR).
The RCI Regensburg Center for Interventional Immunology was established in 2010 as a central unit of Regensburg University in order to tie all academic research areas related to the development of new immunotherapies.
The Chair of Statistics, Faculty of Business Administration at the University of Regensburg, is engaged in the development of methods for quantitative risk management. An emphasis is put on research and consulting projects in developing stochastic methods for risk measurement and controlling.
Service provider as consultancy taxation chambers for freelancers, commercial enterprises, corporations and societies. The spectrum ranges from artisanal businesses and retail operations, temporary employment agencies, health care professions to IT companies and biotechnology companies.
State health insurance company with almost 10 million insured clients, a budget volume of over 33 billion Euros and headquarters in Hamburg. In addition to a central office in the industrial park, TK retains an office in the BioPark for students on the university campus and a direct connection to companies undertaking research.
(at BioPark, founded in 1999, 250 employees) service provider for gene synthesis and downstream processes (DNA engineering and processing). Provides Synthetic Biology for customers of Pharma- and Biotech-industry. Since 2014 GeneArt belongs to the US-based Thermo Fisher Scientific Inc.
(in the BioPark, founded in 2010, 3 employees) works in the area of photodynamic disinfection and decontamination.
The tumorcenter is a health insurance funded non-profit organisation for data transfer, continuous education and improvement of medical processes, for example therapy evaluation, implementations of new therapy strategies in cancer care.
Founded in 1916, our firm is one of the largest in The Netherlands comprising two subsidiaries in Germany, namely in Munich and Regensburg, and one in Belgium.
The establishment of the “Center for Medical Biotechnology” focuses the University activities in the area of Tissue Engineering, cartilage, bone and tumor research. Scientists and clinicians from three different clinical disciplines (Maxillofacial Surgery, Orthopedic Surgery, Trauma Surgery) work together on different aspects of Tissue Engineering with emphasis on regenerative therapy and understanding of pathologies of the musculoskeletal systems.